Tessa Gargett
South Australia Pathology(AU)Royal Adelaide Hospital(AU)University of South Australia(AU)Centre for Cancer Biology(AU)Centre for Cancer Biology(AU)The University of Adelaide(AU)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Nanowire Synthesis and Applications
Most-Cited Works
- → The inducible caspase-9 suicide gene system as a “safety switch†to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells(2014)385 cited
- → GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade(2016)350 cited
- → Genome-Wide Identification of Human FOXP3 Target Genes in Natural Regulatory T Cells(2010)142 cited
- → Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma(2018)108 cited
- → Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2(2015)107 cited
- → GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma